The role of B cells in the pathogenesis of graft-versus-host disease.
about
Interaction between Mesenchymal Stem Cells and B-CellsTherapeutics for Graft-versus-Host Disease: From Conventional Therapies to Novel Virotherapeutic StrategiesTreatment of chronic graft-versus-host disease in 2011Current and emerging strategies for the prevention of graft-versus-host diseaseDisease severity and mortality can be independently regulated in a mouse model of experimental graft versus host diseaseRenal thrombotic microangiopathy associated with chronic graft-versus-host disease after allogeneic hematopoietic stem cell transplantation.Sequential monitoring of lymphocyte subsets and of T-and-B cell neogenesis indexes to identify time-varying immunologic profiles in relation to graft-versus-host disease and relapse after allogeneic stem cell transplantationRegulatory T cells in multiple sclerosis and myasthenia gravis.Current issues in chronic graft-versus-host disease.Advances in graft-versus-host disease biology and therapy.Alteration of naïve and memory B-cell subset in chronic graft-versus-host disease patients after treatment with mesenchymal stromal cells.Rituximab administration within 6 months of T cell-depleted allogeneic SCT is associated with prolonged life-threatening cytopenias.Induction of mixed chimerism using combinatory cell-based immune modulation with mesenchymal stem cells and regulatory T cells for solid-organ transplant tolerance.Effector CD4+ T cells, the cytokines they generate, and GVHD: something old and something new.Aberrant B-cell homeostasis in chronic GVHDThe immunological phenotype of rituximab-sensitive chronic graft-versus-host disease: a phase II studySirolimus, tacrolimus and low-dose methotrexate based graft-versus-host disease prophylaxis after non-ablative or reduced intensity conditioning in related and unrelated donor allogeneic hematopoietic cell transplant.Chemokine receptor CCR5 mediates alloimmune responses in graft-versus-host disease.Acute graft-versus-host disease of the kidney in allogeneic rat bone marrow transplantation.Allogeneic HY antibodies detected 3 months after female-to-male HCT predict chronic GVHD and nonrelapse mortality in humans.Flagellin, a TLR5 agonist, reduces graft-versus-host disease in allogeneic hematopoietic stem cell transplantation recipients while enhancing antiviral immunityThe imbalance between Tregs, Th17 cells and inflammatory cytokines among renal transplant recipients.Cytokines in tear fluid of patients with ocular graft-versus-host disease after allogeneic stem cell transplantation.Proteomic analysis of saliva from patients with oral chronic graft-versus-host diseaseSevere aplastic anemia associated with eosinophilic fasciitis: report of 4 cases and review of the literature.Regulation of pulmonary graft-versus-host disease by IL-26+CD26+CD4 T lymphocytes.Prophylactic rituximab after allogeneic transplantation decreases B-cell alloimmunity with low chronic GVHD incidenceOverview of T-cell depletion in haploidentical stem cell transplantation.B cells from patients with chronic GVHD are activated and primed for survival via BAFF-mediated pathwaysPrevention of graft-vs.-host diseaseImmune reconstitution and graft-versus-host reactions in rat models of allogeneic hematopoietic cell transplantationGenetic Background of Immune Complications after Allogeneic Hematopoietic Stem Cell Transplantation in Children.Antibodies from donor B cells perpetuate cutaneous chronic graft-versus-host disease in mice.Approaches for the prevention of graft-versus-host disease following hematopoietic cell transplantationAugmentation of Recipient Adaptive Alloimmunity by Donor Passenger Lymphocytes within the TransplantIL-21 accelerates xenogeneic graft-versus-host disease correlated with increased B-cell proliferation.Pharmacologic prophylaxis regimens for acute graft-versus-host disease: past, present and future.Donor B cells in transplants augment clonal expansion and survival of pathogenic CD4+ T cells that mediate autoimmune-like chronic graft-versus-host disease.Rituximab prophylaxis prevents corticosteroid-requiring chronic GVHD after allogeneic peripheral blood stem cell transplantation: results of a phase 2 trial.Biology of chronic graft-vs-host disease: Immune mechanisms and progress in biomarker discovery.
P2860
Q26750859-0CC35D01-97D3-432F-BD54-066B3285B40BQ26751959-3EE62DD7-46C0-4466-9EF0-45139BFD6B35Q26851433-A8255ECB-3B1E-44F5-B5DC-9BA61770D6B4Q27016541-8837BF49-ED48-4AE8-AD5F-EF7376A2313EQ27314927-22CDB913-2006-43E5-988E-396EABD007DDQ33396969-F88709ED-5DBA-45DB-9030-5791871637F4Q33554385-5500B13E-D558-4C3E-AF59-12B549EA67BEQ33784969-BDCE889E-DCBD-4122-BBE5-F64ED582EEF4Q33917187-034C80C4-9AA1-423A-93CA-863F6D20C1E8Q34031916-D175C888-0AA3-4522-B9C9-97DF9A3E6193Q34109382-35B9D681-34D6-4638-824E-B9EE4F55FF2DQ34164140-5626625F-1047-4F85-BDD6-C4B328BC703CQ34231351-4E32CDB8-13A1-422A-88CC-536FAB4ECDF0Q34754302-81D54CAF-0AC4-4A64-9781-1D8D4DC90C84Q35171251-ABFCBC63-07F5-408B-A3A3-C900BB7F6674Q35193763-681CB95C-349F-498C-9087-6A2896B01F5FQ35231363-F60F75CB-E686-4491-B3D4-4832E4A2A554Q35237638-6644E139-6457-4807-9E6C-E126842B75F6Q35534266-1EC7A9CA-9A05-4D8B-AD74-52BA39DE8C4BQ35607308-BC01F124-5786-418D-AB96-131F10EB881AQ35691842-BA1D92B6-3269-439D-9CEB-6B72BC60EFF5Q35786069-92A6F5FA-DB40-4541-9F33-5DC317134408Q35883325-0C226E64-50E4-4C09-8FBF-C2C46B5791DEQ36004178-9D92265F-F06A-4DE3-8FED-2B8B43332292Q36009002-EAA1B935-02DB-4CE0-BF77-060AF9E8692BQ36056986-A6D217CC-A583-4B22-8D38-5AE0665CF391Q36057911-3670FF33-627A-4BAC-A8DA-4FA65D1E7453Q36159937-73B0AB4B-5B56-46F6-B3B2-4F6A1C4D3C7CQ36250962-E6767182-1359-4F5A-A3F6-8A6332777AC8Q36431047-85B9D8EE-2CBA-44C4-9172-14FF44C615E8Q36434639-9EAA7ED9-706F-4BBC-8FD0-FD99DE07F5E5Q36531585-5DA987E5-422B-42CB-9034-9F7EA78890D9Q36876981-9B718401-6AA4-40EF-9F46-6BB92C18CEB4Q36891433-4291B499-1BE4-48CD-A28A-104C52095661Q36910447-D265B3A8-A35D-40D1-9553-9EC5A4A9FFC6Q36923019-2208CB24-CF0C-4D33-9C00-269758F78975Q36980277-7610B084-88BD-478E-A65A-2490A4507EEFQ37104281-29B14FD9-FD36-4547-8F61-13C3AF0AF62BQ37113099-A9A43F77-15FF-4D98-A145-4BE21A814FADQ37522548-665A9711-EBBF-4888-B6E5-FBFFC97C75E8
P2860
The role of B cells in the pathogenesis of graft-versus-host disease.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 11 September 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
The role of B cells in the pathogenesis of graft-versus-host disease.
@en
The role of B cells in the pathogenesis of graft-versus-host disease.
@nl
type
label
The role of B cells in the pathogenesis of graft-versus-host disease.
@en
The role of B cells in the pathogenesis of graft-versus-host disease.
@nl
prefLabel
The role of B cells in the pathogenesis of graft-versus-host disease.
@en
The role of B cells in the pathogenesis of graft-versus-host disease.
@nl
P50
P1433
P1476
The role of B cells in the pathogenesis of graft-versus-host disease.
@en
P2093
Michael J Hallek
P304
P356
10.1182/BLOOD-2008-10-161638
P407
P577
2009-09-11T00:00:00Z